Viewing Study NCT00072618


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-01-15 @ 3:13 PM
Study NCT ID: NCT00072618
Status: COMPLETED
Last Update Posted: 2011-10-20
First Post: 2003-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module